Regulatory mechanism of p38MAPK signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine

Zhongguo Zhongyao Zazhi

Volumn 37, Issue 12, 2012, Pages 1700-1704

  Zhao, Qing ^a   Wan, Yigang ^b   Wang, Chaojun ^c   Wei, Qingxue ^a   Chen, Haoli ^a   Meng, Xianjie ^a   Yao, Jian ^d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c Kunshan Hospital of Traditional Chinese Medicine   (China)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chronic kidney disease; p38 mitogen activated protein kinase; Signaling pathway; Traditional Chinese medicine

Indexed keywords

BERBERINE; EMODIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; YISHEN HUOXUE DECOCTION;

ARTICLE; CELL ACTIVATION; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; GLOMERULOSCLEROSIS; GLOMERULUS; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY INJURY; PRESCRIPTION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION; KIDNEY DISEASES; MEDICINE, CHINESE TRADITIONAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84865689518     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20121202     Document Type: Article

References (36)

1. Barsoum R S. Chronic kidney disease in the developing world[J]. N Engl J Med, 2006,354:997.
2. Vidt D G. Inflammation in renal disease[J]. Am J Cardiol, 2006,97:20A.
3. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease[J]. Nephrol Dial Transplant, 2001,7:36.
4. Papayianni A. Cytokines, growth factors and other inflammatory mediators in glomerulonephritis[J]. Ren Fail, 1996,18:725.
5. Han J, Jing Y, Li Z, et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation[J]. Nature, 1997,386:296.
6. Sanz A B, Sanchez-Nino M D, Ramos A M, et al. NF-kappaB in renal inflammation[J]. J Am Soc Nephrol, 2010,21:1254.
7. Cuadrado A, Nebreda A R. Mechanisms and functions of p38 MAPK signalling[J]. Biochem J, 2010,429:403.
8. Cuenda A, Rousseau S. p38 MAP-Kinases pathway regulation, function and role in human diseases[J]. Biochim Biophys Acta, 2007,1773:1358.
9. Ono K, Han J H. The p38 signal transduction pathway activation and function[J]. Cell Signal, 2000,12:1.
10. Tian W, Zhang Z, Cohen D M. MAPK signalling and the kidney[J]. Am J Physiol Renal Physiol, 2000,279:593.
11. Enslen H, Raingeaud J, Davis R J. Selective activation of p38 mitogen activated protein(MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6[J]. J Biol Chem, 1998,273:1741.
12. 1 (I) colagen by TGF-β1 in mesangial cells: role of the p38MAPK pathway[J]. Am J Physiol Renal Physiol, 2001,280:F495.
13. Gruden G, Zonca S, Hayward A, et al. Mechanical stretch-induced fibronectin and transforming growth factor-β1 production in human mesangial cells is p38 mitogen-activated protein kinase dependent[J]. Diabetes, 2000,49:655.
14. Stambe C, Nikolic-Paterson D J, Hill P A, et al. p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury [J]. J Am Soc Nephrol, 2004,15:326.
15. Isaka Y, Fujiwara Y, Ueda N, et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney[J]. J Clin Invest, 1993,92:2597.
16. Border W A, Noble N A, Yamamoto T, et al. Nayural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease[J]. Nature, 1992,360:361.
17. Wan Y, Gu L, Suzuki K, et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody[J]. Nephron Exp Nephrol, 2005,99:e121.
18. Wang J P, Huang H Q, Liu P Q, et al. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats[J]. Eur J Pharmacol, 2006,553:297.
19. Liu W H, Tang F T, Deng Y H, et al. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition[J]. Mol Cell Biochem, 2009,325:99.
20. Ma F Y, Sachchithananthan M, Flanc R S, et al. Mitogen activated protein kinases in renal fibrosis[J]. Front Biosci, 2009,1:171.
21. Zhang Y W, Xie D, Xia B, et al. Suppression of transforming growth factor-beta1 gene expression by Danggui Buxue Tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin- induced diabetic rats[J]. Horm Metab Res, 2006,38:82.
22. Xu H Q, Hao H P. Effects of iridoid total glycoside from cornus officinalison prevention of glomerular overexpression of transforming growth factor beta1 and matrixes in an experimental diabetes model[J]. Biol Pharm Bull, 2004,27:1014.
23. Baud L, Ardaillou R. Tumor necrosis factor in renal injury[J]. Miner Electrolyte Metab, 1995,21:336.
24. Li L S, Liu Z H. Epidemiologic data of renal disease from a single unit in China: analysis based on 13,519 renal biopsies[J]. Kidney Int, 2004,66:920.